Not registered yet? Get a free account.

Sign Up
search icon cancel icon

ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED

Active
Updated: 03 Aug 2025

Actavis Pharma Development Centre Private Limited, is an unlisted private company incorporated on 23 August, 2006. It is classified as a private limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 20.00 cr and the total paid-up capital is INR 13.02 cr.

Actavis Pharma Development Centre's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 13.67% over the previous year. At the same time, it's book networth has increased by 11.0%.

Read more

Subscription Plans
Industry and products
Manufacturing of Pharmaceuticals
  • proprietary drugs, and toiletries ., prescription drugs
Company size
Auth Capital
₹ 20.0 Cr
Paidup Capital
₹ 13.0 Cr
Revenue
₹ 25-50 cr
# Key metrics of Actavis Pharma Development Centre - All rupee values in INR crores. Based on March 2023 numbers. | Metric | Value | Change | |---|---|---| | Auth Capital | ₹ 20.0 Cr | | | Paidup Capital | ₹ 13.0 Cr | | | Revenue | ₹ 25-50 cr | | | Total Revenue | Details available with Tofler Pro subscription | 20.35% | | EBITDA | Details available with Tofler Pro subscription | 13.67% | | Net Profit | Details available with Tofler Pro subscription | 42.7% | | Networth | Details available with Tofler Pro subscription | 11.0% | | Borrowings | Details available with Tofler Pro subscription | None% | | Assets | Details available with Tofler Pro subscription | 10.45% | | Gross Margin | Details available with Tofler Pro subscription | -4.01 | | Operating Margin | Details available with Tofler Pro subscription | -0.78 | | Net Profit Margin | Details available with Tofler Pro subscription | 2.07 | | Return on Equity | Details available with Tofler Pro subscription | 2.14 | | ROCE | Details available with Tofler Pro subscription | 0.48 | | Debt to Equity | Details available with Tofler Pro subscription | 0.0 |
Key Metrics

** All rupee values in INR crores. Based on March 2023 numbers.

Total Revenue
20.35%
₹ GET PRO
EBITDA
13.67%
₹ GET PRO
Net Profit
42.7%
₹ GET PRO
Networth
11.0%
₹ GET PRO
Borrowings
-
₹ GET PRO
Assets
10.45%
₹ GET PRO
Gross Margin
-4.01
GET PRO %
Operating Margin
-0.78
GET PRO %
Net Profit Margin
2.07
GET PRO %
Return on Equity
2.14
GET PRO %
ROCE
0.48
GET PRO %
Debt to Equity
-
GET PRO
Sales
Mar 2023
Net worth
Mar 2023

Locations

indian flag India (2)
State Type Address

location icon Locations on Map

Map placeholder

People

Designation Name DIN/PAN Tenure
Director Sunilkumar Patloba Nagargoje 08623096 6 years
Director Vinod Narayan Shetty 09257187 4 years
Director Nishank Bhargava 09472446 3 years
Kmp Shweta . Agrawal <HIDDEN> 2 years

Financial Highlights

** All numbers in INR crores
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Sales GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Gross margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin GET PRO GET PRO GET PRO GET PRO GET PRO
Networth
Borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Debt to equity GET PRO GET PRO GET PRO GET PRO GET PRO
Current ratio GET PRO GET PRO GET PRO GET PRO GET PRO
ROE GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
WC days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Margins

Gross margin
Operating margin
Net margin

Balance Sheet

%
** All numbers in INR crores
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity Capital GET PRO GET PRO GET PRO GET PRO GET PRO
Reserves GET PRO GET PRO GET PRO GET PRO GET PRO
Borrowings + GET PRO GET PRO GET PRO GET PRO GET PRO
Long term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Short term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Trade payables + GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
Other liabilities + GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Other current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Total liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Tangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
CWIP GET PRO GET PRO GET PRO GET PRO GET PRO
Intangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
LT loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Current assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Inventories GET PRO GET PRO GET PRO GET PRO GET PRO
Trade receivables GET PRO GET PRO GET PRO GET PRO GET PRO
Cash and cash equivalents GET PRO GET PRO GET PRO GET PRO GET PRO
ST loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total assets GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Total assets

Charges on assets

Bank wise
Charges
1

JP Morgan Chase Bank N.A.

No. of Loans: 1

Total Amount : 3.0 cr

chart icon

Charges

JP Morgan Chase Bank N.A.

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address
TEVA HEALTHCARE INDIA PRIVATE LIMITED
Active
6.5 Cr 1 Delhi
TEVA HEALTHCARE INDIA PRIVATE LIMITED
Active
6.5 Cr 1 Maharashtra
TEVAPHARM INDIA PRIVATE LIMITED
Active
220.2 Cr 2 Maharashtra
TEVA PHARMACEUTICAL AND CHEMICAL INDUSTRIES INDIA PRIVATE LIMITED
Active
1.0 L 2 Maharashtra
TEVA API INDIA PRIVATE LIMITED
Active
76.0 Cr 1 Maharashtra
TEVA INDIA PRIVATE LIMITED
Active
12.6 Cr 1 Maharashtra
WATSON PHARMA PRIVATE LIMITED
Active
162.0 Cr 1

Tofler Score

score img
Poor
Fair
Good
Very Good
Excellent

Risk

Severe Risk
  • No risks identified
Moderate Risk
  • No risks identified
Low Risk
  • No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Read more

Registered Details

CIN

U24239MH2006PTC163981

PAN

AAFCA8485P

Incorporation

2006, 19.0 years

Company Email

avani.kansara@actavis.com

Paid up Capital

₹ 13.0 Cr

Authorised Capital

₹ 20.0 Cr

AGM

Aug 2023

Type

Private
Non-government Company

FAQ - ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED

What is the incorporation date of ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED?

plus icon

The incorporation date of ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED is 23 August, 2006

What is the authorized share capital of ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED?

plus icon

The authorized share capital of ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED is INR ₹ 20.0 Cr.

What is the paid-up capital of ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED?

plus icon

The paid-up capital of ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED is INR ₹ 13.0 Cr.

What is the registered address of ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED?

plus icon

The registered address of ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED is 8th Floor, Tower C, Times Square, Andheri Kurla Road, Gamdevi, Marol, Andheri East Mumbai Mumbai City Maharashtra - 400059

What is the CIN number of ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED?

plus icon

The CIN number of ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED is U24239MH2006PTC163981.

Smart Suggestions

  • Uttar Pradesh
  • Haryana
  • Jammu & Kashmir
  • Punjab
  • Goa
  • Madhya Pradesh
  • Kerala
  • Gujarat
  • Andhra Pradesh
  • Telangana
  • Blog Categories
  • Top Blog post
  • Financial Resources
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More